These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 33352739)

  • 1. The Antiasthma Medication Ciclesonide Suppresses Breast Cancer Stem Cells through Inhibition of the Glucocorticoid Receptor Signaling-Dependent YAP Pathway.
    Kim SL; Choi HS; Kim JH; Lee DS
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33352739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FDA-Approved Anti-Asthma Medicine Ciclesonide Inhibits Lung Cancer Stem Cells through Hedgehog Signaling-Mediated SOX2 Regulation.
    Choi HS; Kim SL; Kim JH; Lee DS
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caudatin Isolated from
    Zhen X; Choi HS; Kim JH; Kim SL; Liu R; Ko YC; Yun BS; Lee DS
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32570844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physalin A, 13,14-Seco-16, 24-Cyclo-Steroid, Inhibits Stemness of Breast Cancer Cells by Regulation of Hedgehog Signaling Pathway and Yes-Associated Protein 1 (YAP1).
    Ko YC; Choi HS; Liu R; Lee DS
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiation-induced glucocorticoid receptor promotes CD44+ prostate cancer stem cell growth through activation of SGK1-Wnt/β-catenin signaling.
    Chen F; Chen X; Ren Y; Weng G; Keng PC; Chen Y; Lee SO
    J Mol Med (Berl); 2019 Aug; 97(8):1169-1182. PubMed ID: 31187175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZNF213 negatively controls triple negative breast cancer progression via Hippo/YAP signaling.
    Liu Y; Su P; Zhao W; Li X; Yang X; Fan J; Yang H; Yan C; Mao L; Ding Y; Zhu J; Niu Z; Zhuang T
    Cancer Sci; 2021 Jul; 112(7):2714-2727. PubMed ID: 33939216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STARD13-correlated ceRNA network-directed inhibition on YAP/TAZ activity suppresses stemness of breast cancer via co-regulating Hippo and Rho-GTPase/F-actin signaling.
    Zheng L; Xiang C; Li X; Guo Q; Gao L; Ni H; Xia Y; Xi T
    J Hematol Oncol; 2018 May; 11(1):72. PubMed ID: 29848346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucocorticoid receptor signalling activates YAP in breast cancer.
    Sorrentino G; Ruggeri N; Zannini A; Ingallina E; Bertolio R; Marotta C; Neri C; Cappuzzello E; Forcato M; Rosato A; Mano M; Bicciato S; Del Sal G
    Nat Commun; 2017 Jan; 8():14073. PubMed ID: 28102225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Desmethylsinensetin isolated from Artemisia princeps suppresses the stemness of breast cancer cells via Stat3/IL-6 and Stat3/YAP1 signaling.
    Liu R; Choi HS; Ko YC; Yun BS; Lee DS
    Life Sci; 2021 Sep; 280():119729. PubMed ID: 34146553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
    Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
    Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Expression of Yes-Associated Protein (YAP) Maintains Putative Cancer Stemness and Is Associated with Poor Prognosis in Intrahepatic Cholangiocarcinoma.
    Sugiura K; Mishima T; Takano S; Yoshitomi H; Furukawa K; Takayashiki T; Kuboki S; Takada M; Miyazaki M; Ohtsuka M
    Am J Pathol; 2019 Sep; 189(9):1863-1877. PubMed ID: 31220448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucocorticoid Receptor Signaling Activates TEAD4 to Promote Breast Cancer Progression.
    He L; Yuan L; Sun Y; Wang P; Zhang H; Feng X; Wang Z; Zhang W; Yang C; Zeng YA; Zhao Y; Chen C; Zhang L
    Cancer Res; 2019 Sep; 79(17):4399-4411. PubMed ID: 31289134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells.
    Yang CE; Lee WY; Cheng HW; Chung CH; Mi FL; Lin CW
    Chem Biol Interact; 2019 Apr; 302():28-35. PubMed ID: 30703373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast Cancer.
    Quinn HM; Vogel R; Popp O; Mertins P; Lan L; Messerschmidt C; Landshammer A; Lisek K; Château-Joubert S; Marangoni E; Koren E; Fuchs Y; Birchmeier W
    Cancer Res; 2021 Apr; 81(8):2116-2127. PubMed ID: 33574090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PAR1 participates in the ability of multidrug resistance and tumorigenesis by controlling Hippo-YAP pathway.
    Fujimoto D; Ueda Y; Hirono Y; Goi T; Yamaguchi A
    Oncotarget; 2015 Oct; 6(33):34788-99. PubMed ID: 26431277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
    Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TAZ and YAP are frequently activated oncoproteins in sarcomas.
    Fullenkamp CA; Hall SL; Jaber OI; Pakalniskis BL; Savage EC; Savage JM; Ofori-Amanfo GK; Lambertz AM; Ivins SD; Stipp CS; Miller BJ; Milhem MM; Tanas MR
    Oncotarget; 2016 May; 7(21):30094-108. PubMed ID: 27129148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis.
    Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF
    Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting an Autocrine Regulatory Loop in Cancer Stem-like Cells Impairs the Progression and Chemotherapy Resistance of Bladder Cancer.
    Wang KJ; Wang C; Dai LH; Yang J; Huang H; Ma XJ; Zhou Z; Yang ZY; Xu WD; Hua MM; Lu X; Zeng SX; Wang HQ; Zhang ZS; Cheng YQ; Liu D; Tian QQ; Sun YH; Xu CL
    Clin Cancer Res; 2019 Feb; 25(3):1070-1086. PubMed ID: 30397177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scutellarin Inhibits Proliferation, Invasion, and Tumorigenicity in Human Breast Cancer Cells by Regulating HIPPO-YAP Signaling Pathway.
    Hou L; Chen L; Fang L
    Med Sci Monit; 2017 Oct; 23():5130-5138. PubMed ID: 29079722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.